NFCR Writer David Perry – September 13, 2018 “The trouble with ultrasound is that it doesn’t detect many ovarian cancers early,” says Robert Bast, M.D., Vice President for Translational Research at MD […]
September 5, 2018 A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for […]
“For the vast majority of cancer—breast, prostate, lung, colon and others—if it is detected early when it is a little lump in that organ and it has not spread, you will live. […]
NCI Press Release August 20, 2018 In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with […]
NFCR Press Release NFCR Writer David Perry August 17, 2018 NFCR Breakthroughs The good news is that cocoa is good for you. The seeds of Theobroma cacao are packed with flavonoids, organic […]
NCI Press Release August 15, 2018 Women who had cancer cells detected in their blood 5 years after a breast cancer diagnosis were 13 times more likely to have their cancer return […]
NFCR Press Release NFCR Writer David Perry August 6, 2018 In 2016, archeologists working in the Swartkrans Cave in South Africa found a piece of foot bone belonging to a hominid dating […]
NFCR Press Release NFCR Writer David Perry August 6, 2018 In an attempt to bolster the numbers of minorities in cancer research, the Cleveland-based Case Western Reserve University School of Medicine (CaseMed), […]
